Cytotoxicity and molecular docking analysis of racemolactone I, a new sesquiterpene lactone isolated from Inula racemosa

References

• Ahlemeyer B, Mowes A, Krieglstein J. 1999. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur J Pharmacol. 367(2–3):423–430.
   PubMed Web of Science ®Google Scholar
• AlAjmi MF, Rehman MT, Hussain A, Rather GM. 2018. Pharmacoinformatics approach for the identification of Polo-like kinase-1 inhibitors from natural sources as anti-cancer agents. Int J Biol Macromol. 116:173–181.
   PubMed Web of Science ®Google Scholar
• Al-Shabib NA, Husain FM, Hassan I, Khan MS, Ahmed F, Qais FA, Oves M, Rahman M, Khan RA, Khan A, et al. 2018. Biofabrication of zinc oxide nanoparticle from Ochradenus baccatus leaves: broad-spectrum antibiofilm activity, protein binding studies, and in vivo toxicity and stress studies. J Nanomater. 2018:1–14.
   Web of Science ®Google Scholar
• Arumugam P, Murugan M. 2013. Antimutagenic and antiapoptotic effects of aqueous root extract of Inula racemosa Hook. f. on 4-NQO-induced genetic damage in mice. ISRN Pharmacol. 2013:1–5.
   Google Scholar
• Bohlmann F, Mahanta PK, Jakupovic J, Rastogi RC, Natu AA. 1978. New sesquiterpene lactones from Inula species. Phytochemistry. 17(7):1165–1172.
   Web of Science ®Google Scholar
• Chadwick M, Trewin H, Gawthrop F, Wagstaff C. 2013. Sesquiterpenoids lactones: benefits to plants and people. Int J Mol Sci. 14(6):12780–12805.
   PubMed Web of Science ®Google Scholar
• Farah MA, Ali MA, Chen SM, Li Y, Al-Hemaid FM, Abou-Tarboush FM, Al-Anazi KM, Lee J. 2016. Silver nanoparticles synthesized from Adenium obesum leaf extract induced DNA damage, apoptosis and autophagy via generation of reactive oxygen species. Colloids Surf B Biointerfaces. 141:158–169.
   PubMed Web of Science ®Google Scholar
• Firdous Q, Bhat MF, Hussain MM. 2018. Ethnopharmacology, phytochemistry and biological activity of Inula racemosa Hook. F: a review. Int J Res Ayurveda Pharm. 9(1):95–102.
   Google Scholar
• Gach K, Długosz A, Janecka A. 2015. The role of oxidative stress in anticancer activity of sesquiterpene lactones. Naunyn Schmiedebergs Arch Pharmacol. 388(5):477–486.
   PubMed Web of Science ®Google Scholar
• Gates KS. 2009. An overview of chemical processes that damage cellular DNA: spontaneous hydrolysis, alkylation, and reactions with radicals. Chem Res Toxicol. 22(11):1747–1760.
   PubMed Web of Science ®Google Scholar
• Giordano OS, Guerreiro E, Pestchanker MJ, Guzman J, Pastor D, Guardia T. 1990. The gastric cytoprotective effect of several sesquiterpene lactones. J Nat Prod. 53(4):803–809.
   PubMed Web of Science ®Google Scholar
• Gray PJ, Jr, Bearss DJ, Han H, Nagle R, Tsao MS, Dean N, Von Hoff DD. 2004. Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol Cancer Ther. 3(5):641–646.
   PubMed Web of Science ®Google Scholar
• Grienke U, Radić Brkanac S, Vujčić V, Urban E, Ivanković S, Stojković R, Rollinger JM, Kralj J, Brozovic A, Radić Stojković M. 2018. Biological activity of flavonoids and rare sesquiterpene lactones isolated From Centaurea ragusina L. Front Pharmacol. 9:972.
   PubMed Web of Science ®Google Scholar
• Jiang HL, Chen J, Jin XJ, Yang JL, Li Y, Yao XJ, Wu QX. 2011. Sesquiterpenoids, alantolactone analogues, and seco-guaiene from the roots of Inula helenium. Tetrahedron. 67(47):9193–9198.
   Web of Science ®Google Scholar
• Khan M, Mir SR, Ali A, Yusuf M, Ali M. 2014. Aliphatic and eudesmalolide esters extracted from the roots of Inula racemosa Hook. Pharmacogn Mag. 10(37):40–46.
   PubMed Web of Science ®Google Scholar
• Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. 1999. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res. 59(12):2794–2797.
   PubMed Web of Science ®Google Scholar
• Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A, Kaufmann R. 2002. Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J Cutan Pathol. 29(6):354–358.
   PubMed Web of Science ®Google Scholar
• Kothe M, Kohls D, Low S, Coli R, Cheng AC, Jacques SL, Johnson TL, Lewis C, Loh C, Nonomiya J, et al. 2007. Structure of the catalytic domain of human polo-like kinase 1. Biochemistry. 46(20):5960–5971.
   PubMed Web of Science ®Google Scholar
• Kupchan SM, Eakin MA, Thomas AM. 1971. Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones. J Med Chem. 14(12):1147–1152.
   PubMed Web of Science ®Google Scholar
• Lagoutte R, Winssinger N. 2017. Following the lead from nature with covalent inhibitors. Chimia. 71(10):703–711.
   PubMed Web of Science ®Google Scholar
• Lokhande PD, Gawai KR, Kodam KM, Kuchekar BS, Chabukswar AR, Jagdale SC. 2007. Antibacterial activity of isolated constituents and extract of roots of Inula racemosa. Res J Med Plants. 1(1):7–12.
   Google Scholar
• Malumbres M, Barbacid M. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9(3):153–166.
   PubMed Web of Science ®Google Scholar
• Prehn JHM, Krieglstein J. 1993. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res. 34(2):179–188.
   PubMed Web of Science ®Google Scholar
• Rehman MT, Shamsi H, Khan AU. 2014. Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches. Mol Pharm. 11(6):1785–1797.
   PubMed Web of Science ®Google Scholar
• Reinhardt HC, Yaffe MB. 2013. Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response. Nat Rev Mol Cell Biol. 14(9):563–580.
   PubMed Web of Science ®Google Scholar
• Rizvi SM, Shakil S, Zeeshan M, Khan MS, Shaikh S, Biswas D, Ahmad A, Kamal MA. 2014. An enzoinformatics study targeting polo-like kinases-1 enzyme: comparative assessment of anticancer potential of compounds isolated from leaves of Ageratum houstonianum. Pharmacogn Mag. 10(1):S14–S21.
   PubMedGoogle Scholar
• Sharma V, Hem K, Sharma D, Singh VP, Singh NK. 2016. Ethnopharmacology, phytochemistry and pharmacology of Inula racemosa Hook. F J Nat Prod Resour. 2(1):40–46.
   Google Scholar
• Shin M, McGowan A, Dinatale GJ, Chiramanewong T, Cai T, Connor RE. 2017. Hsp72 Is an intracellular target of the α,β-unsaturated sesquiterpene lactone, parthenolide. ACS Omega. 2(10):7267–7274.
   PubMed Web of Science ®Google Scholar
• Shirole T, Aarti J, Aashish P, Velhankar RD. 2013. Preventive effect of ethanolic extract of ‘Inula racemosa’ on electrocardiographic, biochemical & histopathological alteration in isoproterenol induced myocardial infarction in rats. Int J Res Phytochem Pharmacol. 3:13–22.
   Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175(1):184–191.
   PubMed Web of Science ®Google Scholar
• Slamon D, Pegram M. 2001. Rationale for trastuzumab (herceptin) in adjuvant breast cancer trials. Semin Oncol. 28(1):13–19.
   PubMed Web of Science ®Google Scholar
• Sotillo WS, Villagomez R, Smiljanic S, Huang X, Malakpour A, Kempengren S, Rodrigo G, Almanza G, Sterner O, Oredsson S. 2017. Anti-cancer stem cell activity of a sesquiterpene lactone isolated from Ambrosia arborescens and of a synthetic derivative. PLoS One. 12(9):e0184304.
   PubMed Web of Science ®Google Scholar
• Stevenson CS, Capper EA, Roshak AK, Marquez B, Eichman C, Jackson JR, Mattern M, Gerwick WH, Jacobs RS, Marshall LA. 2002. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore. J Pharmacol Exp Ther. 303(2):858–866.
   PubMed Web of Science ®Google Scholar
• Strebhardt K. 2010. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov. 9(8):643–660.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, Kimura M, Okano Y, Saji S. 2003. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci. 94(2):148–152.
   PubMed Web of Science ®Google Scholar
• Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. 2001. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett. 164(1):41–49.
   PubMed Web of Science ®Google Scholar
• Tavares WR, Seca AML. 2019. Inula L. secondary metabolites against oxidative stress-related human diseases. Antioxidants. 8(5):122.
   Web of Science ®Google Scholar
• Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y. 1999. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol. 15:687–692.
   PubMed Web of Science ®Google Scholar
• Vazquez-Santillan K, Melendez-Zajgla J, Jimenez-Hernandez L, Martínez-Ruiz G, Maldonado V. 2015. NF-κB signaling in cancer stem cells: a promising therapeutic target? Cell Oncol. 38(5):327–339.
   Web of Science ®Google Scholar
• Villagomez R, Quiroz M, Tito A, Sterner O, Almanza GR. 2015. Natural pseudoguaianolides prepared from damsin. Chem Nat Compd. 51(4):675–680.
   Web of Science ®Google Scholar
• Weichert W, Kristiansen G, Winzer KJ, Schmidt M, Gekeler V, Noske A, Müller BM, Niesporek S, Dietel M, Denkert C. 2005. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications. Virchows Arch. 446(4):442–450.
   PubMed Web of Science ®Google Scholar
• Wesołowska A, Nikiforuk A, Michalska K, Kisiel W, Chojnacka-Wójcik E. 2006. Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice. J Ethnopharmacol. 107(2):254–258.
   PubMed Web of Science ®Google Scholar
• Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rübsamen-Waigmann H, Strebhardt K. 1997. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene. 14(5):543–549.
   PubMed Web of Science ®Google Scholar
• Zhang SD, Qin JJ, Jin HZ, Yin YH, Li HL, Yang XW, Li X, Shan L, Zhang WD. 2012. Sesquiterpenoids from Inula racemosa Hook. f. inhibit nitric oxide production. Planta Med. 78(2):166–171.
   PubMed Web of Science ®Google Scholar
• Zhangabylov NS, Dederer LY, Gorbacheva LB, Vasil’eva SV, Terekhov AS, Adekenov SM. 2004. Sesquiterpene lactone arglabin influences DNA synthesis in P388 leukemia cells in vivo. Pharm Chem J. 38(12):651–653.
   Google Scholar